KAYLA POALILLO: Open Payments
NPI 1174373948 · NEWTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$505 in 23 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $505
Food & beverage: $505
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $261 |
| Radius Health, Inc. | 4 | $70 |
| Lilly USA, LLC | 3 | $44 |
| Novo Nordisk Inc | 2 | $42 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| Amgen Inc. | 2 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
Products named: AIRSUPRA, Tymlos, FARXIGA, EVENITY, CAPLYTA, Wegovy, Rybelsus, ROTATEQ.
Industry payments across NJ — which companies pay providers there.
